Related Experiment Video
Updated: Mar 28, 2026
09:01
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.9K
[Langerhans cell sarcoma developing acute myeloid leukemia after achieving complete response by THP-COP]
Kota Hamaguchi1, Akari Hashimoto, Akihito Fujimi
1Department of Hematology and Oncology, Oji General Hospital.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|January 5, 2016
Summary
This case study presents the first documented instance of Langerhans cell sarcoma (LCS) in a patient with idiopathic cytopenia of undetermined significance (ICUS), who later developed acute myeloid leukemia (AML). It highlights the aggressive nature of LCS and its rare association with other hematological malignancies.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Langerhans cell sarcoma (LCS) is an exceptionally rare and aggressive dendritic cell neoplasm, with fewer than 70 cases reported globally.
- Co-occurrence of LCS with other hematological malignancies is infrequently documented.
- Idiopathic cytopenia of undetermined significance (ICUS) represents a state of unexplained low blood cell counts.
